Edition:
United States

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

19.92USD
4:00pm EDT
Change (% chg)

$-0.41 (-2.02%)
Prev Close
$20.33
Open
$20.38
Day's High
$20.41
Day's Low
$19.90
Volume
84,419
Avg. Vol
96,422
52-wk High
$30.06
52-wk Low
$16.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.12 -0.979
FY 2017 Dec '17 1.00 -0.802
Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
FY 2016 Dec '16 0.00 -0.491
Sep '16 0.00 -0.499
Jun '16 0.00 -0.623
Mar '16 0.00 -0.646
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 2.07 3.04 1.00 --
Quarter Ending Sep-18 5 4.54 5.50 3.76 --
Year Ending Dec-18 5 16.69 18.53 14.30 30.12
Year Ending Dec-19 6 70.59 94.13 54.30 132.85
Earnings (per share)
Quarter Ending Jun-18 3 -1.09 -0.94 -1.25 --
Quarter Ending Sep-18 3 -1.15 -1.05 -1.23 --
Year Ending Dec-18 4 -4.15 -3.39 -4.68 -3.14
Year Ending Dec-19 6 -3.25 -2.14 -4.10 -0.77
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.89 34.04
P/E High - Last 5 Yrs. -- 290.95 47.73
P/E Low - Last 5 Yrs. -- 100.14 25.07
Beta -- 0.73 0.78
Price to Sales (TTM) 219.02 249.29 8.22
Price to Book (MRQ) 3.13 23.95 4.29
Price to Tangible Book (MRQ) 3.51 30.87 6.00
Price to Cash Flow (TTM) -- 143.83 22.60
% Owned Institutions 99.89 11.87 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.70
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.18 -6.32
Payout Ratio(TTM) -- 42.00 40.51

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 25.06 5.40
Sales (TTM) vs TTM 1 Yr. Ago -- 135.46 12.76
Sales - 5 Yr. Growth Rate -- 31.25 7.90
EPS (MRQ) vs Qtr. 1 Yr. Ago -103.25 -86.73 41.23
EPS (TTM) vs TTM 1 Yr. Ago -41.81 -- --
EPS - 5 Yr. Growth Rate -- 49.02 8.05
Capital Spending - 5 Yr. Growth Rate -- 36.46 7.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.55
Current Ratio (MRQ) 13.91 6.34 3.62
LT Debt to Equity (MRQ) 0.00 22.40 13.12
Total Debt to Equity (MRQ) 0.07 26.77 17.61
Interest Coverage (TTM) -- -137.51 36.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 22.38 56.81 55.04
Gross Margin - 5 Yr. Avg. -- 55.33 52.94
EBITD Margin (TTM) -3,208.39 -- --
EBITD - 5 Yr. Avg -- -163.88 15.76
Operating Margin (TTM) -3,228.88 -890.63 -0.32
Operating Margin - 5 Yr. Avg. -- -177.36 10.97
Pre-Tax Margin (TTM) -3,142.56 -785.00 1.62
Pre-Tax Margin - 5 Yr. Avg. -- -180.78 11.14
Net Profit Margin (TTM) -3,142.81 -778.64 -1.66
Net Profit Margin - 5 Yr. Avg. -- -179.59 7.49
Effective Tax Rate (TTM) -- 15.47 29.83
Effective Tax Rate - 5 Yr. Avg. -- 19.38 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 29,177 21,870,457 728,113,809
Net Income/Employee (TTM) -916,979 -128,268 84,561,813
Receivable Turnover (TTM) -- 18.25 6.05
Inventory Turnover (TTM) -- 2.86 3.66
Asset Turnover (TTM) 0.01 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.51 -3.57 10.33
Return on Assets - 5 Yr. Avg. -- -0.69 11.01
Return on Investment (TTM) -47.92 -5.30 13.11
Return on Investment - 5 Yr. Avg. -- 2.14 14.30
Return on Equity (TTM) -48.80 -6.83 15.11
Return on Equity - 5 Yr. Avg. -- -2.87 15.65
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -11.52 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.38 5.08 99 78
13 Week 12.88 10.62 99 43
26 Week -13.82 -16.56 97 88
52 Week -21.99 -31.30 99 90
YTD -17.56 -20.35 93 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 145
Total Shares Held: 31,428,853
3 Mo. Net Change: 2,568,734
# New Positions: 14
# Closed Positions: 22
# Increased Positions: 76
# Reduced Positions: 56
# Net Buyers: 20
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.